Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
- PMID:16708058
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
Abstract
Routine vaccination of children is an effective way to reduce hepatitis A incidence in the United States. Since licensure of hepatitis A vaccine during 1995-1996, the hepatitis A childhood immunization strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest disease rates and continuing in 1999 with ACIP's recommendations for vaccination of children living in states, counties, and communities with consistently elevated hepatitis A rates. These updated recommendations represent the final step in the childhood hepatitis A immunization strategy, routine hepatitis A vaccination of children nationwide. Implementation of these recommendations will reinforce existing vaccination programs, extend the benefits associated with hepatitis A vaccination to the rest of the country, and create the foundation for eventual consideration of elimination of indigenous hepatitis A virus transmission. This report updates ACIP's 1999 recommendations concerning the prevention of hepatitis A through immunization (CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 1999:48[No. RR-12]:1-37) and includes 1) new data on the epidemiology of hepatitis A in the era of hepatitis A vaccination of children in selected U.S. areas, 2) results of analyses of the economics of nationwide routine vaccination of children, and 3) recommendations for the routine vaccination of children in the United States. Previous recommendations for vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A are unchanged from the 1999 recommendations.
Similar articles
- Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).[No authors listed][No authors listed]MMWR Recomm Rep. 1999 Oct 1;48(RR-12):1-37.MMWR Recomm Rep. 1999.PMID:10543657
- Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).[No authors listed][No authors listed]MMWR Recomm Rep. 1996 Dec 27;45(RR-15):1-30.MMWR Recomm Rep. 1996.PMID:9005304
- General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).National Center for Immunization and Respiratory Diseases.National Center for Immunization and Respiratory Diseases.MMWR Recomm Rep. 2011 Jan 28;60(2):1-64.MMWR Recomm Rep. 2011.PMID:21293327
- Hepatitis A: disease burden and current childhood vaccination strategies in the United States.Koslap-Petraco MB, Shub M, Judelsohn R.Koslap-Petraco MB, et al.J Pediatr Health Care. 2008 Jan-Feb;22(1):3-11. doi: 10.1016/j.pedhc.2006.12.011.J Pediatr Health Care. 2008.PMID:18174084Review.
- Hepatitis A in the era of vaccination.Wasley A, Fiore A, Bell BP.Wasley A, et al.Epidemiol Rev. 2006;28:101-11. doi: 10.1093/epirev/mxj012. Epub 2006 Jun 14.Epidemiol Rev. 2006.PMID:16775039Review.
Cited by
- Associations Between Environmental and Sociodemographic Data and Hepatitis-A Transmission in Pará State (Brazil).Leal PR, Guimarães RJPSE, Kampel M.Leal PR, et al.Geohealth. 2021 May 1;5(5):e2020GH000327. doi: 10.1029/2020GH000327. eCollection 2021 May.Geohealth. 2021.PMID:34027261Free PMC article.
- Improving immunization delivery using an electronic health record: the ImmProve project.Bundy DG, Persing NM, Solomon BS, King TM, Murakami PN, Thompson RE, Engineer LD, Lehmann CU, Miller MR.Bundy DG, et al.Acad Pediatr. 2013 Sep-Oct;13(5):458-65. doi: 10.1016/j.acap.2013.03.004. Epub 2013 Mar 14.Acad Pediatr. 2013.PMID:23726754Free PMC article.
- Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.Lu PJ, Byrd KK, Murphy TV.Lu PJ, et al.Vaccine. 2013 May 1;31(19):2348-57. doi: 10.1016/j.vaccine.2013.03.011. Epub 2013 Mar 21.Vaccine. 2013.PMID:23523408Free PMC article.
- Integrating hepatitis services into substance abuse treatment programs: new initiatives from SAMHSA.Kresina TF, Hoffman K, Lubran R, Clark HW.Kresina TF, et al.Public Health Rep. 2007;122 Suppl 2(Suppl 2):96-8. doi: 10.1177/00333549071220S219.Public Health Rep. 2007.PMID:17542463Free PMC article.No abstract available.
- Prevalence of Hepatitis B Virus Infection Among US Adults Aged 20-59 Years With a History of Injection Drug Use: National Health and Nutrition Examination Survey, 2001-2016.Shing JZ, Ly KN, Xing J, Teshale EH, Jiles RB.Shing JZ, et al.Clin Infect Dis. 2020 Jun 10;70(12):2619-2627. doi: 10.1093/cid/ciz669.Clin Infect Dis. 2020.PMID:31350875Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical